Regulatory Approvals

BMS wins US FDA approval to expand CAMZYOS to paediatric patients with obstructive HCM

By

Regulatory Approvals — BMS wins US FDA approval to expand CAMZYOS to paediatric patients with obstructive HCM  Dealroom

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 1, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Juvmo for Parkinson’s Disease

Regulatory Approvals

FDA Approves Denosumab Biosimilar for Skeletal-Related Events, GCTB, and Hypercalcemia of Malignancy

Regulatory Approvals

Can You Monitor Glucose Without A Needle Or A Prescription? FDA Clears A New Biosensor

Financial News For All

Mergers & Acquisitions

Paramount-Warner Bros. merger moves forward after judge approves settlement

Mergers & Acquisitions

Federal judge allows Paramount-Warner merger to move forward

Mergers & Acquisitions

Nuveen Completes Acquisition of Schroders

Labor

Duquesne Light workers strike as contract negotiations fail